2026-08-28 · 2026-08 / week-5
Cycurion resets the share count, not the cash conversion
Cycurion resets the share count, not the cash conversion
Summary: U.S. short Watchlist. Cycurion's 1-for-8 reverse split is effective at the Aug. 28, 2026 market open, but the corporate action changes the quoted share unit, not the company's cash conversion. Its June 30 Form 10-Q shows $7.026 million of first-half revenue, yet $6.815 million was advisory consulting and only $4,557 was SaaS. The same filing shows $1.873 million of cash, $6.174 million of first-half operating cash use, a $13.6 million working-capital deficit, and substantial doubt about going concern. The short thesis is a mismatch between a cleaner post-split price and an unproven recurring-revenue bridge. It is not executable: the current quote is after-hours and pre-split, and post-split price acceptance, the share and claim ledger, locate, borrow, spread, depth, and exit liquidity are unverified. This is research, not personalized financial advice.
Opportunity Ranking
| Rank | Candidate | Direction | Mispricing | Evidence Freshness | Catalyst Window | Positioning | 10/5 Status | Tradeability | Main Rejection Risk |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Cycurion (CYCU) | Short | Reverse-split price optics versus advisory-heavy revenue, operating cash burn, and unresolved claims | June 30 10-Q filed Aug. 14, Aug. 26 split release, live Aug. 27 quote | Aug. 28 split and the next cash/share-count filing | Official short-interest page unavailable; conflicting secondary records; live borrow unknown | Watchlist: base -38.0%, adverse +86.0%, ratio 0.44:1 | Current regular quote, spread, depth, venue, and exit data unavailable | A funded equity bridge, creditor accommodation, or reflexive post-split squeeze |
| 2 | Healthy Choice Wellness (HCWC) | Short | 1-for-35 split and merger optics versus sub-$1 million cash and a data-center lease that remains future work | Aug. 7 lease 8-K, Aug. 18 10-Q/A, Aug. 27 split release, live quote | Aug. 28 corporate action, Aug. 31 split-adjusted trading, Host Digital closing path | Lease and merger claims are visible; current borrow and share basis unknown | Watchlist: attractive downside is not enough to offset a binary $1.25 billion lease narrative | After-hours quote only; execution gates unverified | The 15-year take-or-pay lease and a completed merger can overwhelm the cash deficit |
| 3 | CalciMedica (CALC) | Short | Reverse-split price action versus a clinical-stage cash runway and lender conversion claims | June 30 10-Q, June financing disclosure, Aug. 27 split release, live quote | Aug. 28 split and the next financing or clinical update | Cash and financing are documented; current borrow and exit data unknown | Reject for this run: counterparty cash and financing are stronger than CYCU's | After-hours quote only; execution gates unverified | $18.6 million cash and up to roughly $49 million of private-placement capacity support the countercase |
Selected opportunity: Cycurion, Inc. (Nasdaq: CYCU), U.S.-listed common stock.
Why this one now: CYCU has the freshest direct operating mismatch. Its filing separates advisory consulting, MSSP, and SaaS revenue instead of presenting a single cybersecurity growth label. That split matters: $4,557 of first-half SaaS revenue does not support the same valuation story as a recurring software base. At the same time, the company is burning cash and is about to execute a reverse split that can make an unchanged enterprise look more institutionally legible. HCWC has a much larger counterparty claim in its 43 MW data-center lease and merger path. CALC has a documented cash balance and recent financing. Neither offers a cleaner short-side disagreement after downside and financing risk are included.
What should surprise the reader: The reverse split can make the chart look repaired while leaving cash, debt, preferred claims, and the revenue mix untouched. The most important CYCU number is not the new share price. It is the distance between $6.815 million of advisory consulting revenue and $4,557 of SaaS revenue in the same half-year.
Query audit: The screen used mechanism-specific searches combining "reverse split recurring SaaS revenue equity line operating cash debt claims," "post-split price acceptance denominator borrow exit liquidity," "data center merger lease cash runway stock issuance," and "clinical split lender conversion cash runway." No generic earnings query was used.
Why This Is the Best Opportunity Right Now
CYCU's June 30 filing is the strongest primary evidence in this screen because it exposes the operating bridge that a headline cybersecurity label can conceal. First-half revenue fell to $7.026 million from $7.758 million a year earlier, while gross profit rose to $1.782 million from $0.914 million. That gross-margin improvement is real evidence for the counterparty. It does not establish that the business is recurring software: $6.815 million came from advisory consulting, $206,387 from MSSP, and only $4,557 from SaaS.
The cash bridge points the other way. CYCU held $1.873 million of cash and cash equivalents at June 30 and used $6.174 million in operating cash during the first half. The filing reports a $13.6 million working-capital deficit, an accumulated deficit of about $32.8 million, and substantial doubt about going concern. The company also states that its SaaS platform remains in development and is not ready for external sales. These facts make the post-split price a test of capital access and narrative persistence, not proof of recurring cash.
The reverse split is unusually close to the screen. Nasdaq's Aug. 26 release says one old share becomes one-eighth of a new share, expected common shares fall from 25,840,335 to about 3,230,041, authorized shares remain unchanged, and equity awards, warrants, options, and convertibles are adjusted proportionally. That is a mechanical price and denominator translation. It is not a capital infusion, debt repayment, customer collection, or operating turnaround.
Why This Can Move More Than 5% Soon
The latest finance-feed observation was $0.484, up 6.63%, with a $0.4525 to $0.5400 range and 4,900,331 shares traded at 2026-08-27 22:09:22 UTC. It was an after-hours, pre-split observation. On the new share basis, the same reference is approximately $3.872. The split-adjusted print can attract buyers who read a higher nominal price as a listing repair, or sellers who reconcile the unchanged cash deficit and claim ledger.
That is move potential, not a protected trade. There is no verified post-split regular-session quote, bid, ask, depth, venue, volume quality, or exit-liquidity snapshot in this run. A short entered without a current locate and borrow check can lose through a squeeze, recall, buy-in, halt, or gap before a stop can execute.
10/5 Asymmetry Gate
The measurement basis is the $0.484 pre-split reference price, not a verified executable entry. The holding window is Aug. 28 through Sep. 18, 2026, or until the next filing materially changes the cash, claim, or revenue bridge. The scenario levels below are shown on the pre-split basis, with post-split equivalents in parentheses.
- Favorable base move: $0.484 to $0.300 pre-split, or $2.40 post-split equivalent, a 38.0% underlying decline.
- Credible adverse move: $0.484 to $0.900 pre-split, or $7.20 post-split equivalent, an 86.0% squeeze.
- Reference-only weighted price: 0.25 x $0.160 + 0.50 x $0.300 + 0.25 x $0.900 = $0.415.
- Reference-only expected short return: approximately 14.3% before borrow, fees, spread, slippage, recall, financing, and gap costs.
- Gross reward-to-adverse-risk: approximately 0.44:1, below the required 2:1 hurdle.
10/5 status: Reject for current execution; Watchlist for research. The base decline clears 10%, but the credible squeeze case is far beyond 5%, the gross ratio fails, and the entry is null. The favorable arithmetic does not authorize a short.
What Should Surprise the Reader
CYCU can report revenue growth-quality improvement and still fail the recurring-revenue test. Gross profit improved in the first half, but the filing's disaggregation shows that almost all revenue came from advisory consulting. The SaaS product was still described as not ready for external sales. The market can rationally value the possibility of a better business, but it cannot treat that possibility as present SaaS cash.
The second surprise is that the equity line has already produced cash without proving a durable runway. Between July 1 and Aug. 14, CYCU issued 1,050,000 common shares under its Yield Point Equity Purchase Agreement and reported approximately $274,904 of net proceeds. The calculated net proceeds per issued share are about $0.262 before the reverse split. This is evidence of financing activity, not evidence of current post-split float, future draw capacity, or cash sufficiency.
The third surprise is that the reverse split leaves the authorized share count unchanged while adjusting the claims attached to the old units. A post-split quote of $3.872 is economically the same reference as $0.484 before the split unless cash, claims, and operating performance also change.
The Setup
CYCU is a small U.S.-listed company presenting a cybersecurity and services business while developing a SaaS platform. The first-half revenue bridge is:
| Revenue category | H1 2026 | Read-through |
|---|---|---|
| Advisory consulting | $6,814,752 | The dominant reported revenue source; project or service economics need separate recurring evidence |
| MSSP | $206,387 | Some managed-security revenue is present, but the filing does not prove durable retention or cash conversion |
| SaaS | $4,557 | Immaterial to the first-half total and described as not ready for external sales |
| Total revenue | $7,025,696 | A consolidated headline hides the mix that matters for a software valuation |
The filing also records $1.873 million of cash and cash equivalents, total current assets of $5.951 million, first-half operating cash use of $6.174 million, and a $13.6 million working-capital deficit. These are not forecasts. They are the current balance-sheet and cash-flow problem as of June 30.
The Secuvant acquisition adds another claim layer. CYCU disclosed consideration that included $875,000 of cash, 888,888 Series I preferred shares with a stated value of $2 million, and a contingent earnout estimated at $3.1 million, including up to $2.5 million in common stock. The preliminary purchase accounting recorded goodwill of about $6.379 million and negative acquired net assets. The acquisition may improve the operating story. It also means the common-shareholder bridge must include preferred and earnout claims rather than treating the transaction as free revenue.
CYCU's near-term funding path includes the Yield Point equity purchase agreement, existing debt, and the possibility of further equity or claim settlements. An equity-purchase agreement is capacity until a draw, settlement, cash receipt, and post-draw denominator are filed. The reverse split does not resolve those states.
The Market Price
| Metric | Value | Interpretation |
|---|---|---|
| Latest finance-feed price | $0.484 | After-hours, pre-split reference at 2026-08-27 22:09:22 UTC |
| Session change | +$0.0304 / +6.63% | A positive after-hours mark before the corporate action; not price acceptance |
| Intraday high / low | $0.5400 / $0.4525 | The reference is about 7.0% above the session low |
| Volume | 4,900,331 shares | Large relative to the small displayed share base, but venue and quality are not verified |
| Provider market capitalization | $4,387,787 | Context only; it does not reconcile to $0.484 multiplied by the Aug. 10 share count |
| Aug. 10 common shares outstanding | 25,840,335 | Issuer-reported pre-split denominator |
| Expected post-split common shares | About 3,230,041 | Company estimate in the reverse-split release |
| Post-split equivalent reference | About $3.872 | Mechanical 8-for-1 price translation, not a new valuation |
The CYCU Yahoo Finance quote page supplies the after-hours observation and range. The provider market capitalization is not used to compute enterprise value because it conflicts with a simple multiplication of the reported share count and reference price. I do not have sufficient reliable data to quantify a current bid, ask, spread, full depth, venue quality, volume quality, or exit liquidity accurately.
The Mispricing
The market may be pricing a post-split company that looks cleaner, has a more visible share price, and can continue using equity financing. The filing prices a different object: a company whose first-half revenue is advisory-heavy, whose SaaS product is not yet externally ready, and whose operating cash use is several times its cash balance.
The disagreement is not that CYCU must fail. It is that the split can improve price optics without improving the cash conversion required to support a durable rerating. The company can be right if the Secuvant acquisition produces collected, repeatable managed-security revenue, the equity line or another financing supplies enough runway, and gross-margin improvement persists. The short thesis is stronger if the next filing shows the same mix, repeated equity issuance, creditor priority, and no operating-cash repair.
The market-cap mismatch also matters. A provider cap of $4.388 million is not a reliable basis for a valuation conclusion when $0.484 multiplied by 25.840 million shares is approximately $12.5 million. The quote provider may be using a stale or different share basis. That is a data-quality warning, not evidence of additional dilution.
The Positioning
The official Nasdaq CYCU short-interest page did not provide a usable current record in this run. Secondary sources conflict: one record reports 1,103,029 shares short, or 14.85%, at Aug. 14, while another reports approximately 2.4 million shares, or 20.51%, at July 31. Those records may use different share bases or methodologies, and neither is current post-split borrow evidence.
Positioning score: 3/5, capped by missing data. The price and volume suggest a fragile small-cap market structure, but they do not establish a crowded short. Current locate availability, borrow fee, recall terms, securities-lending concentration, official settlement data, options, dealer flow, fund flow, and full order-book depth are unknown. A squeeze must remain in the bottom case rather than being dismissed because the operating filing looks weak.
The Catalyst
| Step | State as of this run | Cheapest test | Bearish interpretation | Squeeze or invalidation path |
|---|---|---|---|---|
| 1-for-8 reverse split | Effective Aug. 28, 2026; split-adjusted trading is expected at the market open | Confirm new CUSIP, adjusted price, adjusted shares, and claim terms | The quote rises mechanically while cash and revenue mix remain unchanged | New price acceptance attracts buyers and creates a reflexive squeeze |
| Post-split price acceptance | Not observed in a regular session | Compare the split-adjusted quote with volume quality, bid/ask, depth, and closing behavior | The market rejects the higher nominal price after the first print | The stock holds above the $7.20 equivalent with a credible cash or financing bridge |
| Yield Point equity line | 1.05 million shares issued for about $274,904 net through Aug. 14 | Verify later draws, registration, settlement, cash receipt, resale, and post-split denominator | Repeated discounted equity competes with the common holder for value | A funded draw supplies runway and validates capital access |
| Secuvant claims | $875,000 cash, Series I preferred, and contingent common earnout disclosed | Confirm preferred terms, earnout settlement, integration revenue, collections, and new shares | Acquisition claims and integration costs absorb scarce cash | Acquired revenue is collected and the claims are settled or refinanced |
| Operating cash conversion | H1 operating cash use was $6.174 million; SaaS was $4,557 | Reconcile next revenue mix, receivables, collections, gross margin, cash, and operating cash | Advisory-heavy revenue does not become recurring SaaS cash | MSSP or SaaS revenue scales with cash collection and positive operating cash |
The cheapest falsification sequence is the post-split share and claim ledger, then the next revenue and collection disclosure, then the cash-flow bridge, and finally a broker-level borrow and exit-liquidity check. A registration or reverse split is not a substitute for those observations.
The Payoff
The top case for the short assumes claim visibility rises after the split while cash remains inadequate and recurring SaaS revenue remains immaterial. The base case assumes the company continues to fund itself conditionally, the acquisition does not yet convert into a clean cash bridge, and the stock gives back part of the split-related price optimism. The bottom case is not a token stop-out. It is a real squeeze driven by a funded draw, creditor accommodation, listing confidence, or an acquisition headline that draws buyers into a narrow market.
The expected value is only a price-only reference calculation. Borrow, recall, spread, slippage, fees, financing, gap, and exit costs could consume the modeled 14.3% expected short return. Since the adverse case is 86.0%, the economics fail the Desk's 2:1 gross reward-to-adverse-risk hurdle before those costs.
Price Target and Probability Map
| Scenario | Probability | Target / Level | Return / Payoff | Horizon | Conditions | Evidence Quality |
|---|---|---|---|---|---|---|
| Top Case for the short | 25% | $0.160 pre-split / $1.280 post-split equivalent | -66.9% underlying | 2 to 8 weeks | Claim issuance or resale becomes visible, cash remains tight, and no funded recurring-revenue surprise appears | Medium. Cash burn and terms are filed; future resale is unknown |
| Base Case | 50% | $0.300 pre-split / $2.400 post-split equivalent | -38.0% underlying | 2 to 8 weeks | The split is absorbed, financing remains conditional or creditor-prioritized, and operating cash does not repair | Medium |
| Bottom Case for the short | 25% | $0.900 pre-split / $7.200 post-split equivalent | +86.0% squeeze | Days to 8 weeks | A funded financing, creditor accommodation, listing confidence, or acquisition narrative creates reflexive demand | Medium-low. Financing capacity is disclosed, but funding and commercial conversion are not proven |
| Invalidation | n/a | Above $0.900 pre-split equivalent with a filed cash and denominator bridge | n/a | Any time | Post-split price acceptance is accompanied by durable recurring revenue, collected cash, and financing that removes repeated discounted-equity dependence | Medium |
Probability-weighted expected value: 0.25 x $0.160 + 0.50 x $0.300 + 0.25 x $0.900 = $0.415 pre-split. That implies approximately 14.3% reference-only expected short return versus $0.484. Executable after-cost EV cannot be computed because entry price is null and the short-side gates are incomplete.
Current market level and timestamp: $0.484, after-hours, pre-split, 2026-08-27 22:09:22 UTC, from Yahoo Finance.
Primary instrument: CYCU common stock only, and only after every short-side gate is independently verified.
10/5 favorable base move: 38.0% decline, reference-only.
10/5 credible adverse move: 86.0% squeeze, reference-only.
10/5 measurement basis: Reference-only, not verified entry.
10/5 status: Reject for current execution; Watchlist for research.
Confidence: Medium-low. The 10-Q, reverse-split release, and quote observation are auditable. The post-split quote, current claim ledger, cash after June 30, equity-line state, official short interest, locate, borrow, and exit liquidity remain unresolved.
The Kill Shot
The strongest counterparty argument is that CYCU does not need to become a pure SaaS company for the stock to work. Gross profit improved sharply, advisory consulting may be profitable, the Secuvant acquisition may add real customers, and the Yield Point facility has already supplied cash. A reverse split can also remove a sub-dollar listing problem and put the stock in a price range that attracts a different buyer set. If a filed financing supplies runway and the acquired MSSP business converts to cash, the present price may be a cheap option on operating repair.
That argument is coherent. The load-bearing bearish assumption is narrower: the next capital-access event will not arrive with enough collected operating evidence to outrun cash burn, senior claims, and dilution. If CYCU files a credible current cash and denominator bridge, shows meaningful recurring MSSP or SaaS collections, and funds operations without repeated discounted equity, this thesis loses its center. A reverse split by itself does not falsify it.
What Could Go Wrong
- A post-split price above the pre-split $0.90 equivalent becomes accepted by the market before the cash problem is resolved.
- Yield Point or another investor funds CYCU on terms that provide enough runway and a powerful financing-validation headline.
- The Secuvant acquisition produces collected, repeatable managed-security revenue sooner than the first-half mix implies.
- Advisory consulting has stronger margins and renewals than the filing's consolidated presentation reveals.
- Preferred, debt, and earnout holders accept terms that reduce immediate common-share pressure.
- A short squeeze develops in a thin market, especially if borrow is recalled or the stock is halted.
- A new filing reconciles the provider's share-count mismatch and shows materially fewer effective claims.
- The split, a later recapitalization, or a new CUSIP changes the price basis while a short remains open.
What Would Prove This Wrong
The thesis should be removed or rebuilt if CYCU files a post-split denominator and claim ledger, receives financing or non-dilutive capital, and shows enough cash for at least twelve months without repeated discounted equity. A binding customer disclosure is not enough by itself. The stronger proof is collected recurring MSSP or SaaS revenue, gross margin, operating cash, and a common-share bridge that includes preferred and earnout claims.
Price alone is also insufficient, but sustained price acceptance above $0.900 pre-split equivalent, or $7.200 post-split equivalent, together with a filed cash repair would invalidate this price map. If the company changes the share basis again, all levels must be rebuilt from the new reference rather than carried forward mechanically.
Risk Audit
| Risk | Current evidence | Control |
|---|---|---|
| Locate, borrow, and recall | Current broker-level evidence is absent; secondary short-interest records conflict | Keep entry price null and execution.can_execute false until locate, borrow fee, recall, and buy-in terms pass |
| Post-split corporate action | The Aug. 28 split has not yet produced a regular-session observation in this run | Do not short through the split or use a stale pre-split price as an order level |
| Spread and depth | Bid, ask, full depth, venue, and exit liquidity are unverified | Require a current top-of-book and realistic exit-liquidity audit; reject market orders |
| Market-cap and denominator mismatch | Provider cap does not reconcile to the Aug. 10 share count times the reference price | Use price-only scenarios; do not compute EV or per-share value until one timestamped ledger reconciles |
| Revenue quality | H1 SaaS was $4,557 against $6.815 million advisory consulting | Track advisory, MSSP, SaaS, collections, gross margin, and operating cash separately |
| Financing and claim priority | Yield Point proceeds, debt, Series I preferred stock, and the Secuvant earnout have different states | Verify draw, cash receipt, settlement, conversion, resale, and post-event denominator in sequence |
| Gap, halt, and squeeze | The modeled bottom case is +86.0% and a 6.63% after-hours rise already occurred | Use small, risk-budgeted exposure only if all gates pass; no leverage, margin, options, or price-floor assumptions |
Best Trade Strategy
Trade expression: CYCU common stock short is a conditional research expression, not a current order.
Entry state: entry price is null. The $0.484 observation is a pre-split after-hours reference. A possible implementation would require a fresh post-split regular-session quote that is not a stale or session-low print, current bid and ask, spread, full depth, venue and volume quality, realistic exit liquidity, a broker-verified locate, borrow fee and recall terms, and a reconciled post-split share and claim ledger. Until then, do not trade.
Targets: Use the price-only map above: $0.300 base and $0.160 top on the pre-split basis, with $0.900 as the modeled bottom-case squeeze. Post-split equivalents are $2.400, $1.280, and $7.200. These are scenario levels, not guaranteed exits or price floors.
Invalidation: Rebuild the thesis after a filed cash and denominator bridge, durable collected MSSP or SaaS revenue, non-dilutive runway, or sustained post-split acceptance above the $0.900 pre-split equivalent with that evidence.
Do-not-trade conditions: No verified locate or borrow; recall or buy-in risk not disclosed; current spread or depth unavailable; price near the session low; a halt or unverified corporate action; unresolved CUSIP or share-basis change; no realistic exit liquidity; or any requirement to use options, leverage, margin, a market order, or a price-floor assumption.
Sources
- Cycurion June 30, 2026 Form 10-Q, filed Aug. 14, 2026. Primary source for revenue disaggregation, cash, operating cash flow, working capital, going-concern language, equity-line issuance, and Secuvant consideration.
- Cycurion reverse-split release, Aug. 26, 2026. Primary corporate-action source for the 1-for-8 split and expected share count.
- Nasdaq CYCU corporate-action alert, Aug. 26, 2026. Exchange notice for the adjusted trading basis.
- CYCU finance quote, observation at 2026-08-27 22:09:22 UTC. After-hours, pre-split market context.
- Nasdaq CYCU short-interest page, accessed Aug. 28, 2026. Current usable official short-interest record was not available in this run.
- ChartExchange CYCU short-interest page, secondary Aug. 14 record. Used only to show conflicting positioning data, not to authorize a locate or borrow.
- Healthy Choice Wellness June 30, 2026 Form 10-Q/A, Aug. 18, 2026.
- Healthy Choice Wellness data-center lease 8-K, Aug. 7, 2026.
- Healthy Choice Wellness reverse-split release, Aug. 27, 2026.
- HCWC finance quote, observation at 2026-08-27 22:14:51 UTC.
- CalciMedica June 30, 2026 Form 10-Q, 2026.
- CalciMedica reverse-split release, Aug. 27, 2026.
- CALC finance quote, observation at 2026-08-27 22:04:25 UTC.
Research Quality Scorecard
| Criterion | Score | Reason |
|---|---|---|
| Market disagreement | 5/5 | Post-split price optics conflict with a filed recurring-revenue and cash-conversion gap |
| Evidence base | 4/5 | Fresh 10-Q, corporate-action notice, and quote; post-period cash and claims remain open |
| Positioning and flows | 2/5 | Official data unavailable, secondary records conflict, and borrow is unverified |
| Catalyst path | 4/5 | Split, post-split acceptance, equity-line state, and the next cash filing are observable |
| Payoff architecture | 3/5 | Scenario map is explicit, but adverse squeeze risk dominates and after-cost EV is unavailable |
| Invalidation discipline | 4/5 | Cash, revenue, denominator, price-acceptance, and execution invalidators are monitorable |
| Differentiated insight | 4/5 | The advisory-to-SaaS mix explains why the cybersecurity label is not a recurring-revenue fact |
| Client value | 4/5 | The note identifies the exact filings and execution gates needed before a short can be considered |
Total: 30/40. Publication classification: Watchlist. Execution classification: Reject. The score clears the Watchlist range, but no score overrides the failed 10/5 and short-execution gates.
Bottom Line
CYCU's reverse split creates a higher quote and a cleaner denominator. It does not create cash, recurring SaaS revenue, or a verified short entry. The best current disagreement is that investors can price the corporate action as a business repair before the next filing proves advisory-to-recurring conversion, cash runway, and claim settlement. The evidence is strong enough for a Watchlist and not strong enough for an executable short.
AI Illustration Prompt
Create a restrained editorial financial illustration for an institutional U.S. short-research note titled "Cycurion resets the share count, not the cash conversion." Show a split-screen accounting still life: on the left, one large old share token being divided into eight smaller tokens with a new price tag rising from $0.484 to $3.872; on the right, a nearly empty cash tray beside a claim ledger. The ledger must visibly separate H1 advisory consulting revenue of $6.815 million, MSSP revenue of $206,387, SaaS revenue of $4,557, H1 operating cash use of $6.174 million, and $1.873 million cash. Add a small Yield Point line item reading 1.05 million shares for $274,904 net, plus muted icons for Series I preferred stock, a $3.1 million earnout, and a going-concern warning. Use charcoal, off-white, muted red, and ledger green; precise typography, generous negative space, documentary light, no trader shouting, no rocket, no bull or bear cartoon, no generic candlestick chart, no invented market data, no logo imitation, and no text other than the named figures and short title.